Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 15/20 | 0.63 |
| ▸ | NPY1R | P25929 | 9/20 | 0.63 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.63 |
| ▸ | NPY2R | P49146 | 5/20 | 0.63 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.58 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.58 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.58 |
| ▸ | TFPI | P10646 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29901561 | 0.94 | NPY4R (0.71) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31666017 | 0.93 | NPY4R (0.71) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29901562 | 0.91 | NPY4R (0.69) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL29767742 | 0.90 | NPY4R (0.72) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29767744 | 0.90 | NPY4R (0.72) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29901565 | 0.89 | NPY4R (0.73) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30578725 | 0.89 | OPRM1 (0.58) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL29406011 | 0.89 | NPY4R (0.64) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL29767743 | 0.89 | NPY4R (0.69) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30827582 | 0.88 | NPY4R (0.70) | NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034167-A1 | HYALURONIC ACID-BASED HYDROGELS FOR JOINT THERAPY | US GOV VETERANS AFFAIRS (US) | 2026-02-05 | — | — | US | disclosed |
| US-20230293775-A1 | BONE-PROMOTING THERMORESPONSIVE MACROMOLECULES | NORTHWESTERN UNIVERSITY | 2023-09-21 | — | — | US | disclosed |
| US-11559609-B2 | Bone-promoting thermoresponsive macromolecules | NORTHWESTERN UNIVESITY (US) | 2023-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034167-A1 | HYALURONIC ACID-BASED HYDROGELS FOR JOINT THERAPY | COL1A1, COL2A1, COL14A1 | NPY4R 86/4885NPY1R 38/4885NPY5R 39/4885 |
| US-11559609-B2 | Bone-promoting thermoresponsive macromolecules | PTN, PLOD3, PNN | NPY4R 2392/4885NPY1R 2435/4885NPY5R 2749/4885 |
| US-20230293775-A1 | BONE-PROMOTING THERMORESPONSIVE MACROMOLECULES | PTN, PLOD3, PNN | NPY4R 2392/4885NPY1R 2435/4885NPY5R 2749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.